Form 4: CRL Officer Mintz Gains Shares from Performance Awards

Sentiment:

Officer Share Transaction


Mark Mintz, EVP and Chief Information Officer at Charles River Laboratories, acquired 1,797 shares of common stock through performance-based awards and subsequently disposed of 655 shares for tax purposes.

Summary

  • Mark Mintz, Executive Vice President and Chief Information Officer of Charles River Laboratories International, Inc. (CRL), reported changes in his beneficial ownership.
  • On January 30, 2026, Mintz acquired 1,797 shares of common stock at a price of $0 per share.
  • This acquisition reflects shares issued following the achievement of performance goals related to performance share unit awards originally granted on May 26, 2023.
  • On the same date, January 30, 2026, Mintz disposed of 655 shares of common stock at a price of $211.68 per share.
  • Following these transactions, Mintz's direct beneficial ownership of common stock stands at 7,492 shares.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, as it signifies the achievement of performance goals and a net increase in executive ownership, aligning management interests with shareholders.

Positives

  • The acquisition of 1,797 shares indicates the achievement of performance goals set forth in previously granted performance share unit awards, reflecting positive company performance.
  • The net increase in beneficial ownership (1,797 shares acquired minus 655 shares disposed for tax, resulting in a net gain of 1,142 shares) aligns the executive's interests further with shareholders.

Negatives

  • The disposition of 655 shares, likely for tax withholding purposes, reduces the total number of shares held by the executive compared to the gross award.

Future Outlook

The filing does not contain any forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that performance-based equity awards are a standard component of executive compensation packages in the life sciences and pharmaceutical services industry. This structure aims to align executive incentives with the long-term performance and strategic objectives of the company, such as Charles River Laboratories.

Stakeholder Impact

  • Shareholders: A net increase in executive share ownership can be viewed positively as it indicates management's continued alignment with shareholder interests and confidence in the company's future performance.
  • Employees: The vesting of performance awards can serve as a positive signal regarding the company's ability to meet its strategic and financial objectives.

Key Dates

DateDescription
05/26/2023Original grant date of performance share unit awards.
01/30/2026Date of common stock issuance following performance goal achievement and subsequent disposition for tax.
02/02/2026Signature date of the reporting person on the Form 4 filing.

Recommendation

hold

This Form 4 filing details a routine executive compensation event involving the vesting of performance share units and subsequent tax-related share disposition. While it indicates the achievement of performance goals and a net increase in executive ownership, it does not present new fundamental information that would warrant a change in investment recommendation. Investors should consider broader company performance and market conditions.

Keywords

Charles River Laboratories, CRL, Mark Mintz, Form 4, Insider Trading, Performance Share Units, Executive Compensation, Stock Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.